9 0

새로운 당뇨병 치료제 Pramlintide의 Systematic Review

Title
새로운 당뇨병 치료제 Pramlintide의 Systematic Review
Author
최한곤
Keywords
Pramlintide; Bridging study; Clinical trial; Pharmacokinetic study; Pharmacodynamic study
Issue Date
2006-12
Publisher
대한약학회
Citation
약학회지, v. 50, No. 6, Page. 386-392
Abstract
Pramlintide, a synthetic analogue of human hormone amylin, is the first of a new class of amylinomimetic compounds. Present study was undertaken to compile and analyze the clinical trials of pramlintide, and thereby to facilitate the design of the bridging study for the earlier introduction of the drug, which might be needed by diabetes patients in Korea. Sixty-two articles from Pubmed and MEDLINE search were used to analyze the trials of pramlintide along with prescribing information and New Drug Application packet obtained from the manufacturer. The efficacy of the new drug was attributed to three mechanisms: delay of gastric emptying time, inhibition of post-prandial glucagon secretion, and reduction of food intake by enhanced satiety. Clinical trials consistently identified the effectiveness of the drug for the treatment of type 1 and type 2 diabetes who have failed to achieve glycemic control despite optimal therapy with insulin. However, the six pivotal Phase Ⅲ clinical trials were performed with mostly caucasian and some black and hispanic people.
URI
http://scholar.dkyobobook.co.kr/searchDetail.laf?barcode=4010024015845http://repository.hanyang.ac.kr/handle/20.500.11754/109982
ISSN
0377-9556
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE